About
Technology
Issues
FAQ
Links
Official Page
Clinical experience with the
BCL
2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.